NCT06100042Completed
Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting
Multicentre, Prospective, Non-interventional Study Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
TriMaximize is a non-interventional study aimed to collect prospective data from asthmatic patients under routine care, for whom their treating physician has decided to prescribe BDP/FF/G (beclomethasone/formoterol/glycopyrronium).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 233 (actual)
- First submitted
- 20 Oct 2023
- Start date
- 24 Apr 2024
- Primary completion date
- 12 Jun 2026
- Lead sponsor
- Chiesi Italia
- Diseases
- Asthma
- NCT number
- NCT06100042
What you commit to
- Study type: Observational
- Participants enrolled: 233
- From 24 Apr 2024 to the primary completion date, 12 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in an interventional clinical trial within 30 days prior to enrolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.
Who the study is looking for
- Patients ≥ 18 years of age;
- Patients with confirmed leading diagnosis of asthma with or without concomitant COPD;
- Physician decision to start fixed triple therapy with ICS/LABA/LAMA (BDP/FF/G) MS or HS according to its current authorised indication and current reimbursement conditions within the Italian National Health System. The treatment decision must be made independently from participation in this study and may have started within the previous 4 weeks (maximum);
- Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| U.O. Clinica Psichiatrica e SPDC. Ospedale Policlinico S. Martino - IRCCS, Genova Coordinator of this site? Confirm its status | Genoa | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.